12-month primary endpoint outcomes of the bioadaptor-rct - europcr 2023
Published 1 year ago • 878 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
43:36
restoring vessel physiology and function with dynamx bioadaptor: the holy grail of pci -europcr 2023
-
0:55
fast-tavi ii #europcr preview from the #thoraxcenter
-
46:16
angiography-based ffr: from clinical evidence to daily practice - europcr 2023
-
44:00
the challenge of the diabetic patient with diffuse coronary artery disease - europcr 2022
-
16:58
latest evidence and experiences on ultra-thin strut stenting - europcr 2023
-
1:00:24
contemporary best clinical practice for tavi - europcr 2023
-
8:13
how have revived results changed my practice? - europcr 2023
-
7:47
latest on tavi in complex bicuspid lesions - europcr 2023
-
11:02
what are the essential skillsets for aspiring mitral teer operators? - europcr 2023
-
17:29
corflow moca i trial: fih direct measurement of mvo in stemi - europcr 2023
-
45:45
tavi lifetime management: tailoring treatment options to secure future possibilities - europcr 2023
-
13:26
what are the inoca endotypes and how to diagnose? - europcr 2023
-
2:58
resolute onyx 2.0mm in extra small vessel primary endpoint results - europcr 2017
-
1:47
provisional stenting in #bifurcation lesion: benefit of side branch intervention? europcr 2023
-
4:30
europcr 2023 – why is it a must-attend event?
-
1:02:08
cutting-edge technologies: clinical updates on tes, brs, tavr and laa closure - europcr 2023
-
44:46
the cathlab of the future - europcr 2022
-
6:02
biostemi: translating ultrathin des technology into superior stemi patient outcomes - europcr 2021
-
2:29
outcomes of repeat tavr with balloon-expandable valves - europcr 2023
-
48:35
knocking mitral regurgitation down to improve outcomes: earlier is better, better late than never!
-
8:00
europcr 2024 highlights: coronary interventions